Logo image of UROV

Urovant Sciences Ltd (UROV) Stock Price, Quote, News and Overview

NASDAQ:UROV - Nasdaq -

16.24  +0.01 (+0.06%)

After market: 16.23 -0.01 (-0.06%)

UROV Quote, Performance and Key Statistics

Urovant Sciences Ltd

NASDAQ:UROV (3/26/2021, 8:05:43 PM)

After market: 16.23 -0.01 (-0.06%)

16.24

+0.01 (+0.06%)

Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A
Statistics
52 Week High16.26
52 Week Low7.15
Market Cap531.75M
Shares32.74M
Float28.97M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPON/A N/A


UROV short term performance overview.The bars show the price performance of UROV in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 20 40 60

UROV long term performance overview.The bars show the price performance of UROV in the last 1, 2 and 3 years. 1 year 2 years 3 years 20 40 60

The current stock price of UROV is 16.24 null. In the past month the price increased by 0.43%. In the past year, price increased by 62.89%.

Urovant Sciences Ltd / UROV Daily stock chart

About UROV

Company Profile

Urovant Sciences Ltd. is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing therapies for urologic conditions. The company's product candidate pipeline consists of vibegron, an oral, once-daily, small molecule beta-3 agonist being evaluated in an international pivotal Phase 3 clinical trial for the treatment of overactive bladder. hMaxi-K, is a novel gene therapy being developed for patients with overactive bladder who have failed oral pharmacological therapy. Urovant Sciences Ltd. is based in Floor London, United Kingdom.

Company Info

Urovant Sciences Ltd

11-12 STREET JAMES SQUARE SUITE 1 3RD FLOOR

LONDON X0 SW1Y 4LB

CEO: James Robinson

Phone: 44-0-20-7400-3347

Urovant Sciences Ltd / UROV FAQ

What is the stock price of Urovant Sciences Ltd today?

The current stock price of UROV is 16.24 null. The price increased by 0.06% in the last trading session.


What is the ticker symbol for Urovant Sciences Ltd stock?

The exchange symbol of Urovant Sciences Ltd is UROV and it is listed on the Nasdaq exchange.


On which exchange is UROV stock listed?

UROV stock is listed on the Nasdaq exchange.


What is Urovant Sciences Ltd worth?

Urovant Sciences Ltd (UROV) has a market capitalization of 531.75M null. This makes UROV a Small Cap stock.


What are the support and resistance levels for Urovant Sciences Ltd (UROV) stock?

Urovant Sciences Ltd (UROV) has a support level at 16.23 and a resistance level at 16.25. Check the full technical report for a detailed analysis of UROV support and resistance levels.


Should I buy Urovant Sciences Ltd (UROV) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does Urovant Sciences Ltd (UROV) stock pay dividends?

UROV does not pay a dividend.


What is the Price/Earnings (PE) ratio of Urovant Sciences Ltd (UROV)?

Urovant Sciences Ltd (UROV) does not have a PE ratio as the earnings reported over the last twelve months were negative (-5.14).


UROV Technical Analysis

ChartMill assigns a technical rating of 7 / 10 to UROV. When comparing the yearly performance of all stocks, UROV turns out to be only a medium performer in the overall market: it outperformed 43.41% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

UROV Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to UROV. UROV has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

UROV Financial Highlights

Over the last trailing twelve months UROV reported a non-GAAP Earnings per Share(EPS) of -5.140000000000001. The EPS decreased by -25.06% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -150.35%
ROE N/A
Debt/Equity -1.44
Chartmill High Growth Momentum
EPS Q2Q%-7.35%
Sales Q2Q%N/A
EPS 1Y (TTM)-25.06%
Revenue 1Y (TTM)N/A

UROV Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 60% to UROV. The Buy consensus is the average rating of analysts ratings from 3 analysts.


Ownership
Inst Owners19.1%
Ins Owners70.43%
Short Float %N/A
Short RatioN/A
Analysts
Analysts60
Price TargetN/A
EPS Next Y-27.81%
Revenue Next YearN/A